International Primary Care Respiratory Group
|
|||||||||
|
News
Excerpts from April 2004 European Respiratory Journal
By Dr Hetty van Dijk, IPCRG web editor
Respiratory symptoms more likely to disappear if you stop smoking
Obstructive sleep apnoea syndrome is a common disorder with an estimated prevalence of at least 2 to 4% among middle aged adults, especially common in obesity. Leptin is a substance produced in the adipose tissue and which plays an important role in the control of body weight, but also in reproduction and neuroendocrine signalling. Recent studies could document that there is a relation between sleep apnoea and leptin levels. Bernd M. Sanner and colleagues from Wuppertal, Germany, therefore tested the hypothesis that treatment of the sleep disorder influences leptin levels. Eighty-six patients participated in the study, 59 were treated effectively, 27 ineffectively or not at all. Effective treatment reduced the blood levels of leptin, while they remained unchanged or increased in the other group. Furthermore there was an independent relation between the change of leptin levels with treatment and the degree of improvement of nocturnal respiration. The authors therefore conclude that obstructive sleep apnoea syndrome is not only a condition that worsens quality of sleep, but also a disease with a substantial influence on human's health. Quality of dietary fat is associated with allergies In a German study, performed by a multidisciplinary group of researchers led by Joachim Heinrich, it was shown that the quality of dietary fat is associated with the risk of hay fever and allergic sensitization, but not atopic eczema and bronchial hyperreactivity. The associations were most pronounced for increased intake of monounsaturated fatty acids and oleic acids in relationship with hay fever and allergic sensitization in women. Apart from allergenic food and the exposure to aeroallergens also non-allergenic dietary factors might be involved in the development of hay fever and allergic sensitization. How clean are your lungs? The airways that conduct air into and out of the lung contain secretions -mucus- that trap inhaled particles. These are removed from the lung by a process called mucociliary clearance that moves the mucus, dead cells and inhaled particles and microorganisms towards the throat from where they are swallowed. Patients with respiratory disease such as chronic obstructive pulmonary disease (COPD) typically have more secretions and products of infections in their airways. Mucociliary clearance, an important component of lung function, has usually been measured using a technique that determines the rate of removal of inhaled radiolabelled aerosols from the lung, but can only be carried out in medical facilities that have specialised equipment. Lucy Morgan and colleagues from Concord, Australia, developed a simpler technique that uses a much lower dose of radioactivity, take much less time and equipment and can be used in any nuclear medicine department. The new technique involves injecting a small volume (0.1ml) of fluid through the cricothyroid membrane just below the trachea, after applying anaesthetic cream. The fluid contains albumen spheres labelled with radioactive technetium that are deposited in the trachea. Their movement towards the larynx is detected and measured with a gamma camera. After a 15 minute period of observation the rate of mucociliary clearance can be calculated. The technique causes minimal discomfort. |
||||||||
The content of this site, unless otherwise specified, is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 2.0 License 2002-2008 International Primary Care Respiratory
Group. Click here for information on Disclaimer, Copyright Notice, E-mail and Privacy Policy.
|
|||||||||
Page updated on September 24 2005 Website developed and maintained by danzigdesigns.com • Hosted by Dr Simon Child |
|||||||||